NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹279 Cr | ₹258 Cr | ₹218 Cr | ₹199 Cr | ₹150 Cr |
What is the latest Appropriations of NGL FINECHEM ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹279 Cr |
| Mar2025 | ₹258 Cr |
| Mar2024 | ₹218 Cr |
| Mar2023 | ₹199 Cr |
| Mar2022 | ₹150 Cr |
How is Appropriations of NGL FINECHEM Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹279 Cr | 7.82 | |
| Mar2025 | ₹258 Cr | 18.36 | |
| Mar2024 | ₹218 Cr | 9.71 | |
| Mar2023 | ₹199 Cr | 32.45 | |
| Mar2022 | ₹150 Cr | - | |
Compare Appropriations of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹2,135.2 Cr | 5.2% | 11.4% | 168.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 5.2% |
11.4% |
168.9% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses